India slashes cost of 137 cancer drugs after landmark court case

India will apply a 30% trade-margin cap to 137 cancer drugs starting next month, following a landmark Supreme Court ruling against abusive mark-ups in a patient’s case. The government says prices could fall by up to 70%, easing out-of-pocket costs in a country where treatment bills push many families into debt or out of care.